Phase 1/2 study of HST-1011, an oral CBL-B inhibitor, alone and in combination with anti-PD1 in patients with advanced solid tumors Jason Luke,Rachel E. Sanborn, Jordi Rodon,Manish Patel, Parul Agarwal,Evan Friedman, Connacht Peterson, Heather Kelley, Emma Wright, Hadi Danaee,Huadong Sun, Carolin Barth, Timothy Reilly, Amanda J. Redig,Claire FriedmanCANCER RESEARCH（2023）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
